Skip to main content
Figure 4 | Genome Medicine

Figure 4

From: Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy

Figure 4

Increased levels of Calreticulin and GRP75/Mortalin in skin biopsies correlate with disease progression in SMA mice. (A) Representative fluorescent western blots on skin tissue from 'Taiwanese’ SMA mice and littermate controls at P9 (mid/late-symptomatic) showing levels of GRP75/Mortalin, Calreticulin and Ponceau (loading control). (B,D) Bar charts (mean ± standard error of the mean) showing expression levels of GRP75/mortalin and Calreticulin in 'Taiwanese’ SMA mice (knockout (KO)) and controls at P9 (N = 3 mice per genotype). (B) GRP75/Mortalin levels were significantly increased in 'Taiwanese’ SMA mice compared with controls (***P < 0.01, unpaired, two-tailed t-test). (D) Calreticulin levels were significantly increased in Taiwanese SMA mice compared with controls (**P < 0.01, unpaired, two-tailed t-test). (C,E) Time course of GRP75/Mortalin and Calreticulin expression in skin biopsies from 'Taiwanese’ SMA mice (KO) compared to controls (Het) (N = 3 mice per genotype/time-point). Tissue was analysed in mice at P1, P5 (both pre/early-symptomatic), P7 (early-symptomatic) and P9 (mid/late-symptomatic). (C) There was no increase in GRP75/Mortalin levels in Taiwanese SMA mice until after overt disease onset. (E) Similarly, there was no increase in Calreticulin levels in Taiwanese SMA mice until after overt disease onset.

Back to article page